Oncotarget

Vol 11, No 25

June 23, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 25 of Oncotarget features Figure 8, "BI-D1870 in combination with vincristine increase metaphase arrest and apoptosis synergistically," by Chae, et al.

Table of Contents

News

MYC’xing it up: zebrafish B ALL models provide insight into MYC-driven disease and relapse

MYC’xing it up: zebrafish B ALL models provide insight into MYC-driven disease and relapse

https://doi.org/10.18632/oncotarget.27644

Diana Sá da Bandeira,  and Wilson K. Clements
2372-2374
PDF  |  How to cite  |  Order a Reprint

Research Papers

Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma

Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma

https://doi.org/10.18632/oncotarget.27629

Elizabeth Shay, Naseer Sangwan, Roshan Padmanabhan, Scott Lundy, Brian Burkey,  and Charis Eng
2375-2386
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit

https://doi.org/10.18632/oncotarget.27630

Hee-Don Chae, Ritika Dutta, Bruce Tiu, Fieke W. Hoff, Benedetta Accordi, Valentina Serafin, Minyoung Youn, Min Huang, Nathan Sumarsono, Kara L. Davis, Norman J. Lacayo, Martina Pigazzi, Terzah M. Horton, Steven M. Kornblau,  and Kathleen M. Sakamoto
2387-2403
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Mutation profile of primary subungual melanomas in Caucasians

Mutation profile of primary subungual melanomas in Caucasians

https://doi.org/10.18632/oncotarget.27642

Aneta Borkowska, Anna Szumera-Ciećkiewicz, Mateusz Spałek, Paweł Teterycz, Anna Czarnecka, Artur Kowalik,  and Piotr Rutkowski
2404-2413
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trial

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trial

https://doi.org/10.18632/oncotarget.27643

Toshiyasu Ojima, Masaki Nakamura, Keiji Hayata, Junya Kitadani, Masahiro Katsuda, Mikihito Nakamori, Akihiro Takeuchi, Shimpei Maruoka, Naoki Fukuda, Shinta Tominaga, Hideki Motobayashi,  and Hiroki Yamaue
2414-2423
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter

Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter

https://doi.org/10.18632/oncotarget.27645

Rive Sarfstein,  and Haim Werner
2424-2437
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1

Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1

https://doi.org/10.18632/oncotarget.27646

Erik L. Brincks, James Adams, Lifu Wang, Benjamin Turner, Agnieszka Marcinowicz, Jiyuan Ke, Michael Essmann, Lucía M. Mautino, Clarissa Van Allen, Sanjeev Kumar, Nicholas Vahanian, Charles Link,  and Mario R. Mautino
2438-2461
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Corrections

Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

https://doi.org/10.18632/oncotarget.27403

Caroline M. Robb, Smit Kour, Jacob I. Contreras, Ekta Agarwal, Carter J. Barger, Sandeep Rana, Yogesh Sonawane, Beth K. Neilsen, Margaret Taylor, Smitha Kizhake, Rhishikesh N. Thakare, Sanjib Chowdhury, Jing Wang, Jennifer D. Black, Michael A. Hollingsworth, Michael G. Brattain,  and Amarnath Natarajan
2462-2463
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC